Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05022693
What this trial is testing

PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 8
Not applicableStudy completedNCT05527938
What this trial is testing

Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Children

Who this might be right for
NAFLDWebChildhood Obesity
Shaoxing Maternity and Child Health Care Hospital 85
Not applicableLooking for participantsNCT04054310
What this trial is testing

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Perspectum 225
Not applicableNot Yet RecruitingNCT06537466
What this trial is testing

Ketogenic Diet in MASLD-related cACLD

Who this might be right for
Steatohepatitis, NonalcoholicSteatosis of LiverCirrhosis, Liver
University of Palermo 50
Not applicableLooking for participantsNCT04232566
What this trial is testing

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Who this might be right for
Obesity, MorbidNASH - Nonalcoholic SteatohepatitisChronic Inflammation
Mayo Clinic 60
Testing effectiveness (Phase 2)Study completedNCT03763877
What this trial is testing

The Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver
Poxel SA 121
Early research (Phase 1)Study completedNCT06037577
What this trial is testing

Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)Systemic Sclerosis (SSc)
ChemomAb Ltd. 8
Post-approval studies (Phase 4)Study completedNCT03222206
What this trial is testing

The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty LiverOsteo Arthritis
Korea University Guro Hospital 34
Not applicableLooking for participantsNCT06115876
What this trial is testing

Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program

Who this might be right for
Diabetes Mellitus Type 2, Diabetes Mellitus Type 1NAFLD - Nonalcoholic Fatty Liver DiseasePreDiabetes
Dasman Diabetes Institute 2,000
Testing effectiveness (Phase 2)WithdrawnNCT04216693
What this trial is testing

Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicableEnded earlyNCT04284371
What this trial is testing

The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients

Who this might be right for
Steatohepatitis, NonalcoholicHemosiderosisOverweight Adolescents+2 more
The Geneva Foundation 150
Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Large-scale testing (Phase 3)UnknownNCT05308160
What this trial is testing

A Single Center, Randomized, Open Label, Parallel Group, Phase 3 Study to Evaluate the Efficacy of Dapagliflozin in Subjects With Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
National Taiwan University Hospital 75
Early research (Phase 1)Study completedNCT03031119
What this trial is testing

Multiple Ascending Dose and DDI Study

Who this might be right for
Healthy Volunteers
Pfizer 62
Not applicableLooking for participantsNCT03572465
What this trial is testing

Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
Centre hospitalier de l'Université de Montréal (CHUM) 102
Testing effectiveness (Phase 2)Ended earlyNCT00845845
What this trial is testing

Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Hepatic Steatosis
University of Illinois at Chicago 12
Not applicableStudy completedNCT04677101
What this trial is testing

Liquid Biopsy for NASH and Liver Fibrosis

Who this might be right for
NASH - Nonalcoholic SteatohepatitisLiver Fibroses
Catholic University of the Sacred Heart 150
Not applicableStudy completedNCT05497765
What this trial is testing

An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Guangzhou Medical University 94
Testing effectiveness (Phase 2)Study completedNCT04321031
What this trial is testing

Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis With Liver Fibrosis
Pfizer 256
Not applicableStudy completedNCT03915002
What this trial is testing

Integrated Approaches for Identifying Molecular Targets in Liver Disease

Who this might be right for
Alcoholic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseSteatohepatitis, Nonalcoholic+1 more
University of Pittsburgh 155
Next Page